Product Images Erlotinib Hydrochloride

Erlotinib Tablets are a medication containing erlotinib hydrochloride, indicated for certain types of cancer treatment. Each film-coated tablet contains 100mg of the drug. The enclosed package insert should be consulted for complete prescribing information, including recommended dosage. These tablets should be stored at a controlled room temperature of 15°C to 30°C (59°F to 86°F). Erlotinib Tablets are manufactured in India by MSN Laboratories Private Limited and distributed in the US by MSN Pharmaceuticals Inc. It is important to keep them out of reach of children.*

Each tablet of Erlotinib hydrochloride contains 100 mg of erlotinib (as free base). It is a prescription medicine and the standard dosage is mentioned in the enclosed package. The tablets are film-coated and manufactured by MSN Laboratories Private Limited, based in Telangana, India. The medicine is distributed in the US by MSN Pharmaceuticals Inc. and comes in a pack of 30 tablets. It should be stored at controlled room temperature, between 15°C to 30°C (59°F to 86°F), and kept out of reach from children. The package insert contains complete prescribing information for the medicine.*

This is a description of Erlotinib Tablets, a medicine that comes in a container with 30 tablets, manufactured by MSN Laboratories Private Limited in Telangana, India and distributed by MSN Pharmaceuticals Inc. in Piscataway, NJ. Each film-coated tablet contains 25mg of Erlotinib hydrochloride. The full prescribing information is available in the enclosed package. It is advised to store the medicine between 15°C to 30°C (59°F to 86°F). This medicine should be kept out of reach of children. The text further includes some codes and numbers, stating that it's only for use with a doctor's prescription.*

Each tablet of Erlotinib contains 25mg erlotinib hydrochloride. It is prescribed medication and should be stored between 15° to 30°C. The medication contains 30 tablets and is manufactured by MSN Laboratories Private Limited in Telangana, India. It is distributed by MSN Pharmaceuticals in Piscataway, NJ. For complete prescribing information, the insert should be referred to. Keep out of reach of children.*

This appears to be a chart showing the survival probability for patients at different intervals over a period of 33 months. There are two groups of patients, one labeled "Placebo" and the other labeled "Erlotinib". The numbers listed under each category represent the number of patients at those intervals.*

This data seems to be a graphical representation of survival probability for patients, based on a study that involved a placebo and erlotinib medication. The graph shows the number of patients at risk for both the placebo and erlotinib, along the months of the study. There are textual labels for Survival Probability and Overall Survival, along with the units of months for the time axis. There are no textual descriptions of the medications, dosage, or the study itself, hence more information is needed to make conclusion or other statements.*